MENU
+Compare
RNXT
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$0.91
Change
-$0.09 (-9.00%)
Capitalization
32.36M

RNXT RenovoRx Forecast, Technical & Fundamental Analysis

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RNXT with price predictions
Apr 03, 2025

Momentum Indicator for RNXT turns negative, indicating new downward trend

RNXT saw its Momentum Indicator move below the 0 level on April 03, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned negative. In of the 68 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for RNXT moved below the 200-day moving average on March 27, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RNXT's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 46 cases where RNXT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RNXT just turned positive on March 11, 2025. Looking at past instances where RNXT's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RNXT advanced for three days, in of 157 cases, the price rose further within the following month. The odds of a continued upward trend are .

RNXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 62 cases where RNXT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.577) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (248.206).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RNXT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNXT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RNXT is expected to report earnings to rise 9.09% to -11 cents per share on May 19

RenovoRx RNXT Stock Earnings Reports
Q1'25
Est.
$-0.12
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Est.
$-0.10
Q1'24
Est.
$-0.07
The last earnings report on April 01 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 92.66K shares outstanding, the current market capitalization sits at 32.36M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRM0.690.32
+87.76%
MEDIROM Healthcare Technologies
DM4.96N/A
N/A
Desktop Metal
BMI184.92-10.85
-5.54%
Badger Meter
PRU104.79-7.92
-7.03%
Prudential Financial
CLMT11.96-1.19
-9.05%
Calumet Inc.

RNXT and Stocks

Correlation & Price change

A.I.dvisor tells us that RNXT and SPRB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and SPRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-9.00%
SPRB - RNXT
29%
Poorly correlated
-0.10%
IMRX - RNXT
26%
Poorly correlated
-3.85%
VTVT - RNXT
24%
Poorly correlated
-0.06%
TARA - RNXT
24%
Poorly correlated
+0.82%
SLNCF - RNXT
24%
Poorly correlated
N/A
More